| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/18/2001 | WO2000062743A3 Skin care compositions containing combination of skin care actives |
| 01/18/2001 | WO2000057918A3 Novel formulations comprising lipid-regulating agents |
| 01/18/2001 | WO2000056299A3 The use of amifostine for the protection against tumor metastasis formation |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000047215A3 Methods for anti-tumor therapy |
| 01/18/2001 | WO2000043014A8 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 01/18/2001 | WO2000040227A3 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 01/18/2001 | WO2000037067A3 Sensitizing agents for the treatment of skin lesions |
| 01/18/2001 | WO2000035492A3 Vitronectin receptor antagonist pharmaceuticals |
| 01/18/2001 | WO2000034245A3 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase |
| 01/18/2001 | WO2000031092A3 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation |
| 01/18/2001 | WO2000024360A8 Preparation and use of solidified oils |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | WO1999050403A3 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 01/18/2001 | DE19934088A1 Neue C-19-halogensubstituierte Steroide der Androst-9(11)-en-Reihe, Verfahren zu ihrer Herstellung sowie ihre Verwendung New C-19 halogen-substituted steroids of androst-9 (11) -en-series, processes for their preparation and their use |
| 01/18/2001 | DE19932796A1 Diacylhydrazinderivate Diacylhydrazinderivate |
| 01/18/2001 | DE19932653A1 Eye-drops for treating cataracts, contain natural or synthetic partial components of bile fluid which eliminate light refracting small hardened protein particles |
| 01/18/2001 | DE19932651A1 Transdermales therapeutisches System zur Anwendung von Tolterodin Transdermal therapeutic system for application of tolterodine |
| 01/18/2001 | DE19932555A1 Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen Drugs with a protective effect against oxidative-toxic and in particular against cardiotoxic substances |
| 01/18/2001 | DE19932197A1 Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung Topically applied agents with protective and regenerative effect |
| 01/18/2001 | DE19932157A1 Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln Method for the gentle production of ultrafine microparticles and nanoparticles |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |
| 01/18/2001 | CA2687396A1 Treatment of neurotic disorders |
| 01/18/2001 | CA2687394A1 Treatment of neurotic disorders |
| 01/18/2001 | CA2687392A1 Treatment of neurotic disorders |
| 01/18/2001 | CA2416233A1 Compositions and methods for the treatment of parkinson's disease |
| 01/18/2001 | CA2379345A1 T-cell receptor .gamma. alternate reading frame protein, (tarp) and uses thereof |
| 01/18/2001 | CA2379199A1 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods |
| 01/18/2001 | CA2379149A1 Neurotrophic pyrrolidines and piperidines, and related compositions and methods |
| 01/18/2001 | CA2379035A1 Staurosporin derivatives |
| 01/18/2001 | CA2378653A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | CA2378600A1 Amino ceramide-like compounds and therapeutic methods of use |
| 01/18/2001 | CA2378595A1 Benzoylpyridazines |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378562A1 Method for producing oligopolysaccharides |
| 01/18/2001 | CA2378515A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | CA2378465A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | CA2378402A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 01/18/2001 | CA2378305A1 New 2,3-benzodiazepine derivatives |
| 01/18/2001 | CA2378291A1 Quinazoline derivatives |
| 01/18/2001 | CA2378018A1 Heartburn treatment |
| 01/18/2001 | CA2378014A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 01/18/2001 | CA2377999A1 Compositions and methods for raising hdl cholesterol levels |
| 01/18/2001 | CA2377918A1 Compositions and methods for promoting nerve regeneration |
| 01/18/2001 | CA2377902A1 Novel prodrugs for antimicrobial amidines |
| 01/18/2001 | CA2377502A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/18/2001 | CA2376029A1 Use of pyridoxin derivatives for the treatment of diabetes and related complications |
| 01/18/2001 | CA2375992A1 Method for controlled production of ultrafine microparticles and nanoparticles |
| 01/18/2001 | CA2375647A1 Use of flavones, coumarins and related compounds to treat infections |
| 01/18/2001 | CA2375628A1 Compounds for inhibiting diseases and preparing cells for transplantation |
| 01/18/2001 | CA2374411A1 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/18/2001 | CA2341035A1 Pulmonary delivery of liposomal-encapsulated cannabinoids |
| 01/18/2001 | CA2340757A1 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/17/2001 | EP1069142A1 Water soluble polymers and their use in cosmetic and pharmaceutic products |
| 01/17/2001 | EP1069132A1 Bicyclic derivatives of amino-pyrazinones, process of preparation and pharmaceutical compositions comprising them |
| 01/17/2001 | EP1069125A2 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
| 01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
| 01/17/2001 | EP1069114A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/17/2001 | EP1069111A1 Indole derivatives with antiviral activity |
| 01/17/2001 | EP1069110A1 Sulfonamide derivatives |
| 01/17/2001 | EP1069106A2 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity |
| 01/17/2001 | EP1069105A1 Novel capsaicinoide-like substances having ester bond |
| 01/17/2001 | EP1068870A1 Antitumor agents |
| 01/17/2001 | EP1068869A2 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 01/17/2001 | EP1068868A2 Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration |
| 01/17/2001 | EP1068867A2 Pharmaceutical tablet comprising an NSAID and misoprostol |
| 01/17/2001 | EP1068865A1 Use of 4,6-dimethoxy-indole 2 carboxylic acid or derivatives thereof for seborrhea treatment |
| 01/17/2001 | EP1068864A1 Use of at least a hydroxystilbene as a glycation inhibitor |
| 01/17/2001 | EP1068858A1 Use of 4,6-dimethoxyindole-2-carboxylic acid for stimulating or inducing hair growth and/or arresting hair loss |
| 01/17/2001 | EP1068524A1 Corticotropin releasing factor receptor 1-deficient mice |
| 01/17/2001 | EP1068357A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
| 01/17/2001 | EP1068327A2 DNA IMMUNIZATION AGAINST $i(CHLAMYDIA) INFECTION |
| 01/17/2001 | EP1068304A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily |
| 01/17/2001 | EP1068219A1 Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 01/17/2001 | EP1068215A1 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 01/17/2001 | EP1068212A1 THIAZOLO 4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| 01/17/2001 | EP1068211A2 Process for purification of a cephalosporin derivative |
| 01/17/2001 | EP1068210A2 Process for the production of purine derivatives |
| 01/17/2001 | EP1068208A1 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them |
| 01/17/2001 | EP1068207A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES |
| 01/17/2001 | EP1068206A1 Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
| 01/17/2001 | EP1068205A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands |
| 01/17/2001 | EP1068202A1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists |
| 01/17/2001 | EP1068200A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/17/2001 | EP1068199A2 N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
| 01/17/2001 | EP1068198A1 5-heteroaryl substituted indoles |
| 01/17/2001 | EP1068196A1 Nitrate salt of anti-ulcer medicine |
| 01/17/2001 | EP1068195A1 Antagonists of gonadotropin releasing hormone |
| 01/17/2001 | EP1068194A1 Pde iv inhibiting pyridine derivatives |
| 01/17/2001 | EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists |
| 01/17/2001 | EP1068192A1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
| 01/17/2001 | EP1068191A1 Benzoxazinones/benzothiazinones as serine protease inhibitors |
| 01/17/2001 | EP1068190A1 Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
| 01/17/2001 | EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 01/17/2001 | EP1068188A1 Novel nucleic acid transfer agents, compositions containing same and uses |
| 01/17/2001 | EP1068187A1 Pyrazole inhibitors of cytokine production |
| 01/17/2001 | EP1068186A2 Pharmaceutical compositions and methods for use |
| 01/17/2001 | EP1068185A1 Compounds with activity on muscarinic receptors |
| 01/17/2001 | EP1068184A1 N-aryloxyethylamine derivatives for the treatment of depression |